Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Rigosertib 592542-59-1 10mg
SDP

Supplier:  Apexbio Technology LLC B128810

Encompass_Preferred

Rigosertib (CAS 592542-59-1) is a small molecule that functions as a dual inhibitor of phosphoinositide 3-kinase (PI3K) and polo-like kinase 1 (PLK1) In cellular models Rigosertib suppresses the PI3K/AKT signaling pathway downregulates cyclin D1 induces pro-apoptotic proteins NOXA and BIM and activates the JNK pathway It promotes apoptosis in a range of human tumor cell lines including breast prostate ovarian pancreatic small cell lung colorectal cancers and melanoma with reported IC50 values typically between 50 90 nM Rigosertib is also active against drug-resistant tumor lines and influences cell cycle progression causing arrest at G1 and G2/M phases in both normal and malignant cells This profile supports its utility in cancer research particularly studies of apoptosis cell cycle regulation and kinase signaling pathways

Catalog No. 50-000-88206


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.